Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.

When the World Health Organization's top donor the United States announced its withdrawal, one employee launched an online ...

Thirty patients have received the gene therapy within a clinical trial and early-access program, and the foundation also hopes to seek approval in the US.

Catch up with the most important stories from around Europe and beyond - latest news, breaking news, World, Business, ...